Sapkal Nidhi P, Kilor Vaishali A, Shewale Bharti D, Bhusari K P, Daud A S
Gurunanak College of Pharmacy, Near Dixit Nagar, Nari, Nagpur-440 026, India.
Indian J Pharm Sci. 2010 May;72(3):318-23. doi: 10.4103/0250-474X.70477.
Fexofenadine is a selective histamine H(1) receptor antagonist, used for relief of the symptoms of allergy. However its aqueous solubility is very poor. Solid inclusion complexes of fexofenadine and β-cyclodextrin were prepared at the molar ratios of 1:1 and 1:2 by kneading, and coprecipitation methods to improve its solubility. Characterization of the complexes was performed using infrared spectroscopy, X-ray diffractometry, and in vitro dissolution studies. Fexofenadine was found to exhibit interaction with β-cyclodextrin both in solid and liquid state. Phase solubility studies indicated that fexofenadine forms a stable complex with β-cyclodextrin. Both IR spectroscopy and X-ray diffractometry studies indicated interaction of fexofenadine with β-cyclodextrin. Kneading method at 1:1 and co-precipitation method at 1:1 and 1:2 molar ratios showed significant interaction. In vitro dissolution studies confirmed the same results.
非索非那定是一种选择性组胺H(1)受体拮抗剂,用于缓解过敏症状。然而,其水溶性很差。通过捏合和共沉淀法,以1:1和1:2的摩尔比制备了非索非那定与β-环糊精的固体包合物,以提高其溶解度。使用红外光谱、X射线衍射法和体外溶出度研究对包合物进行了表征。发现非索非那定在固态和液态下均与β-环糊精发生相互作用。相溶解度研究表明,非索非那定与β-环糊精形成稳定的包合物。红外光谱和X射线衍射法研究均表明非索非那定与β-环糊精发生了相互作用。1:1摩尔比的捏合法以及1:1和1:2摩尔比的共沉淀法均显示出显著的相互作用。体外溶出度研究证实了相同的结果。